Abstract
AAA. See Abdominal aortic aneurysm
Abdominal aorta, 223–226
Abdominal aortic aneurysm (AAA)
animal models, 343–350 colorectal cancer and, 119–122 endovascular repair, 1–7, 17–22, 186–191, 264–289 horseshoe kidney with, 27–31 proteolysis in, 9–15 rupture, 38–41, 130–135 surgery, 27–31
ACEIs. See Angiotensin-converting enzyme inhibitors
Acute limb ischemia, 156–160
Adenosine diphosphate, 353–360
Agenesis, 43–45, 109–112
Amputation, 63–68
Amsterdam Acute Aneurysm Trial, 130–135
Analgesia, 75–79
Anesthesia
general, 17–22 local, 99–100 regional, 23–26
Aneurysm
atherosclerotic, 173–175 para-anastomotic, 206–211 popliteal, 103–107, 227–230, 297–303 sac thrombus, 348 superior mesenteric artery, 109–112 thoracic, 161–164, 267–268, 270–280
See also Aortic aneurysm; Endovascular aneurysm repair; Pseudoaneurysm
Angiogenesis, 321–326
Angiography, 43–45
Angioplasty
infrageniculate, 63–68 percutaneous transluminal, 81–86
Angiotensin-converting enzyme inhibitors (ACEIs), 99
Animal models, 332–335, 343–350, 353–360
Anticoagulants, 96–98
Antiplatelets, 93-96
Antithrombotics, 238–239
Aortic aneurysm
infected, 165–168 inflammatory, 206–211 laparoscopic repair, 186–191 suture, 161–164
See also Abdominal aortic aneurysm
Aortic arch, 43–45
Aortic infection, 165–168
Aortic isthmus restenosis, 161–164
Aortic surgery, 27–31, 186–191
Aortotomy, 51–53
Aortouni-iliac (AUI) stent grafts, 136–141
Arterial embolism, 156–160
Arterial flow, 149–153
Arterial occlusive disease
infrainguinal, 290–295 lower extremity, 313–317 popliteal, 201–205 superficial femoral, 81–86
Arterial stenosis, 290–295
Arterial thrombosis, 51–53
Arteriography, 201–205
Arteriovenous fistula (AVF)
carotid stenting, 123–129 native, 70–74 upper extremity, 23–26
Aspirin, 93–95
Atherectomy, 313–317
Atherosclerosis
carotid, 88–91 percutaneous, 270–280 peripheral, 193–199 popliteal, 201–205, 297–303 SilverHawk device, 313–317
Atherosclerotic aneurysm, 173–175
AUI. See Aortouni-iliac (AUI) stent grafts
AVF. See Arteriovenous fistula
Below-the-knee CHILL study, 295–296
Beta blockers, 98
Biomarkers, 193–199
Bleeding, 32–37
Blood flow, 70–74
Blunt abdominal aortic injury, 223–226
Blunt trauma, 123–129, 223–226
Bone marrow, 328–335
Bradykinin, 353–360
Bypass
femorofemoral, 136–141 infrainguinal, 113–117 long saphenous vein, 113–117 popliteal, 103–107, 201–205 tissue-engineered, 338–342
Calcium ionophore A23187, 353–360
Cancer, 119–122
See also Carcinoma
Canine models, 343–346
Carboplatin, 51–53
Carcinoma
ovarian, 51–53
See also Cancer
Carotid artery, 43–45, 75–79
Carotid artery stenting (CAS)
arteriovenous fistulae, 123–129 coronary wire, 219–221 with distal protection, 237–243 psueudoaneurysm, 123–129 transcervical, 245–254 virtual simulation training in, 256–263
Carotid atherosclerosis, 88–91
Carotid endarterectomy (CEA)
pharmacology, 93–100 pseudoaneurysm after, 177–180 for stroke prevention, 237–243
Carotid plaque, 88–91
Carotid plexus block, 75-79
Carotid pseudoaneurysm, 123–129, 177–180
Carotid surgery, 75–79, 177–180
Carotid Wallstent, 237–243
CAS. See Carotid artery stenting
CCA. See Common carotid artery
CEA. See Carotid endarterectomy
Celiac artery, 109–112
Cerebrovascular symptoms, 88–91
Cervical plexus block (CPB), 75–79
CFA. See Common femoral artery
Chemotherapy, 51–53
CHILL study, 295–296
Chronic lymphocytic leukemia (CLL), 165–168
Claudication, 81–86, 169–171
CLI. See Critical limb ischemia
CLL. See Chronic lymphocytic leukemia
Clopidogrel, 95–96
Colorectal cancer, 119–122
Common carotid artery (CCA), 177–180
Common femoral artery (CFA), 219–221
Computed tomography (CT), 27–31, 47–50, 123–129, 136–141, 161–168
Computer-assisted instrumentation, 256–263
Coronary through wire, 219–221
CPB. See Cervical plexus block
C-reactive protein (CRP), 193–199
Critical bleeding, 32–37
Critical ischemia, 201–205
Critical limb ischemia (CLI), 63–68, 113–117, 142–148, 321–326
CRP. See C-reactive protein
Cryoplasty, 290–295
CT. See Computed tomography
Cystic adventitial disease, 167–171
Cytokines, 193–199
Deep venous thrombosis (DVT), 47–50, 305–312
Delay, 38–41
Deoxyribonucleic acid. See DNA
Descending genicular artery (DGA), 201–205
Descending thoracic aorta
aneurysm, 212–217 endovascular repair, 212–217
Dextran, 97–98
DGA. See Descending genicular artery
Diabetes, 328–335
Diethrich, Edward B., 181-185
DNA, 362–364
Duplex scanning (DS), 149–153
DVT. See Deep venous thrombosis
Embolism, 156–160
Emerging technology, 366–370
Endoextension, 247–248
Endoleak, 264–269, 346–347
Endothelial denudation, 353–360
Endothelial progenitor cells (EPCs), 328–335
Endothelial vasoreactivity, 353–360
Endovascular aneurysm repair (EVAR)
abdominal aortic, 1–7, 17–22, 119–122, 130–135, 186–191, 264–289 Amsterdam Acute Aneurysm Trial, 130–135 aortic suture, 161–164 with aortouni-iliac stent grafts, 136–141 popliteal artery, 103–107, 297–303 thoracic aortic, 161–164, 212–217, 282–289
Endovascular grafting, 103–107
Endovascular repair
blunt abdominal aortic injury, 223–226 deep venous thrombosis, 305–312 exclusion of subclavian artery pseudoaneurysm, 231–234 graft, 103–107 limb salvage, 63–68 oversized introducer sheath, 353–360
See also Endovascular aneurysm repair
End-stage renal disease, 70–74
EPCs. See Endothelial progenitor cells
Ethics, 130–135
European Collaborators on Stent-Graft Techniques for Abdominal Aortic Aneurysm Repair (EUROSTAR), 1–7
EUROSTAR. See European Collaborators on Stent-Graft Techniques for Abdominal Aortic Aneurysm Repair
EVAR. See Endovascular aneurysm repair
Exclusion, 227–230, 231–234
External reinforced vein, 113–117
FeAST. See Iron (Fe) and Atherosclerosis Study
Femoral artery, 290–295
Femorofemoral bypass, 136–141
Ferritin, 193–199
Fibrinolysis, 9–15
Filters, 305–312
FilterWire distal protection, 237–243
Flow
arterial, 149–153 of blood, 70–74 reversal, 245–254 vessel dynamics, 367–368
General anesthesia, 17–22
Genicular artery, 201–205
Graft
endovascular, 103–107 interposition, 177–180 occlusion, 156–160 prosthetic, 156–160 saphenous vein, 113–117, 173–175 stent, 103–107, 123–129, 136–141, 231–234, 282–289, 297–303 tissue-engineered, 338–342 vascular, 338–342
G2 Filter, 309
Günther Tulip Filter, 308
Hemodialysis, 70–74
Hemodynamic arterial color-flow, 149–153
Hemodynamic lability, 17–22
Hemorrhage, 32–37
Heparin, 96–97
HIF-1. See Hypoxia-inducible factor (HIF)-1
Horseshoe kidney, 27–31
Hyperbaric oxygen, 328–335
Hyperoxia, 328–335
Hypoxia-inducible factor (HIF)-1, 321–324
IAAs. See Inflammatory aortic aneurysms
ICA. See Internal carotid artery
IDOR. See Intraoperative direct outflow resistance
Iliac artery, 353–360
Iliofemoral artery, 167–171
Infection, aortic aneurysm, 165–168
Inferior vena cava (IVC)
filters, 305–312 left, 47–50
Inflammation, 362–364
Inflammatory aortic aneurysms (IAAs), 206–211
Inflammatory markers, 193–199
Infrageniculate angioplasty, 63–68
Infrageniculate stenting, 63–68
Infrainguinal arterial occlusive disease, 290–295, 313–317
Infrainguinal bypass, 113–117
Infrapopliteal procedures, 63–68
In-stent restenosis, 237–243
Internal carotid artery (ICA), 43–45, 177–180
Intraluminal thrombus, 9–15
Intraoperative direct outflow resistance (IDOR), 149–153
Intravascular ultrasonography (IVUS), 353–360
Introducer sheath, 353–360
Iron (Fe) and Atherosclerosis Study (FeAST), 193–199
Ischemia
cerebrovascular, 88–91 critical, 63–68, 113–117, 142–148, 201–205, 321–326 limb, 63–68, 113–117, 142–160, 169–171, 297–303, 313–317, 321–326 myocardial, 362–364
IVC. See Inferior vena cava
IVUS. See Intravscular ultrasonography
Ketorolac, 75–79
Klippel-Feil syndrome, 43–45
Laparoscopic aortic surgery, 186–191
Laparoscopic assisted surgery, 186–191
Laser, 63–68
Lateral sural artery, 201–205
Left inferior vena cava, 47–50
Left retroperitoneal exposure, 27–31
Legal issues, 130–135
Leukemia, 165–168
Ligation, 227–230
Limb
ischemia, 63–68, 113–117, 142–160, 169–171, 297–303, 313–317, 321–326 revascularization, 149–153 salvage, 63–68, 142–148
Local anesthesia, 99–100
Long saphenous vein, 113–117
Lower extremity
arterial occlusive disease, 313–317 claudication, 169–171 ischemia, 63–68, 113–117, 142–160, 169–171, 297–303, 313–317, 321–326 revascularization, 149–153 saphenous vein graft, 173–175
Lymphocytic leukemia, 165–168
Magnetic resonance imaging (MRI), 43–45, 366–370
May-Thurner syndrome, 47–50
Medial sural artery (MSA), 201–205
Mesenteric artery, 109–112
Mouse studies, 332–335, 348–349
MRI. See Magnetic resonance imaging
Myocardial ischemia, 362–364
Native arteriovenous fistula, 70–74
Neck, 246–247
Neuroprotection, 245–254
Nitric oxide, 353–360
Nocardia asteroides, 165–168
Occlusion
arterial, 81–86, 156–160, 290–295, 313–317 graft, 156–160
OPTEASE Filter, 309–312
Outflow, 149–153
Ovarian carcinoma, 51–53
Oversized introducer sheath, 353–360
Pancreaticoduodenal artery, 109–112
Para-anastomotic aneurysm, 206–211
Paraplegia, 212–217
Paravertebral blockade (PVB), 17–22
PARP. See Poly(ADP-ribose) polymerase
Percutaneous transluminal angioplasty (PTA)
in arterial stenosis, 290–295 stenting and, 81–86
Peripheral arterial disease (PAD)
diabetic wound healing in, 328–335 inflammatory markers in, 193–199 occlusion, 156–160 treprostinil sodium for, 142–148
Peripheral arterial embolism, 156–160
Peripheral vascular disease (PVD), 297–303, 313–317, 321–326
Pharmacology, 93–100
Plaque, 88–91, 313–317, 366–370
Plasmin, 9–15
Plavix. See Clopidogrel
PolarCath system, 291
Poly(ADP-ribose) polymerase (PARP), 362–364
Popliteal artery (PA)
aneurysm, 103–107, 227–230, 297–303 atherosclerotic occlusion, 297–303 cryoplasty, 290–295
Porcine model, 353–360
Pressure sensor, 264–269
Propofol, 17–22
Prostacyclin, 142–148
Prostar XL Perclose device, 273–280
Prosthetic graft, 156–160
Proteolysis, 9–15
PSA. See Pseudoaneurysm
Pseudoaneurysm (PSA)
arteriovenous fistula, 123–129 carotid, 123–129, 177–180 subclavian, 231–234
Psychomotor performance, 256–263
PTA. See Percutaneous transluminal angioplasty
PVB. See Paravertebral blockade
PVD. See Peripheral vascular disease
Quantitative analysis, 366–370
Recombinant activated factor VII (rFVIIa), 32–37
Regional anesthesia, 23–26
Reinforced vein, 113–117
Remodulin. See Treprostinil sodium
Renal disease, 70–74
Reperfusion, 362–364
Restenosis
aortic isthmus, 161–164 in-stent, 237–243
Rest pain, 142–148
Retrievable vena cava filters, 305–312
Revascularization, 149–153
rFVIIa. See Recombinant activated factor VII
Runoff, 149–153
Rupture
abdominal aortic aneurysm, 38–41, 130–135 popliteal artery aneurysm, 227–230
Sac thrombus, 348
Salmonella, 165–168
Saphenous vein graft, 113–117, 173–175
Scaffold, 338–339
Serotonin, 353–360
SilverHawk Plaque Excision System, 313–317
Skeletal muscle, 321–326
SMA. See Superior mesenteric artery
STA. See Superficial temporal artery
Staphylococcus aureus, 165–168
Statins, 1–7, 98-99, 193–199
Stem cells, 338–342
Stenosis, 290–295
Stent
graft, 103–107, 123–129, 136–141, 231–234, 282–289, 297–303 infrageniculate, 63–68 percutaneous transluminal angioplasty and, 81–86
See also Carotid artery stenting
Stroke, 88–91, 237–243
Subclavian artery, 231–234
Superficial femoral artery occlusive disease, 81–86
Superficial temporal artery (STA), 219–221
Superior mesenteric artery (SMA), 109–112
Sural arteries, 201–205
Surgery
aortic, 27–31, 186–191 carotid, 75–79, 177–180 endovascular, 181–185 laparoscopic assisted, 186–191 vascular, 32–37, 319–320, 338–342, 362–364
See also Endovascular aneurysm repair; Endovascular repair; specific procedures
Suture, 161–164
Technology, 366–370
Thoracic aorta
aneurysm, 161–164, 267–289 disease, 212–217
See also Descending thoracic aorta
Thrombectomy, 51–53, 305–312
Thrombocytopenia, 32–37
Thrombolysis, 305–312
Thrombosis
arterial, 51–53 deep venous, 47–50, 305–312 graft, 156–160
Thrombus
intraluminal, 9–15 sac, 348
Through-and-through wire technique, 219–221
Through-wire technique, 231–234
Tissue
engineering, 338–342 hyperoxia, 328–335
TNF. See Tumor necrosis factor
Total laparoscopic aortic surgery, 186–191
Transcervical carotid artery stenting, 245–254
Trauma, 123–129, 223–226
Treprostinil sodium, 142–148
Tumor necrosis factor (TNF), 193–199
TX2 stent graft, 282–289
Type 1 endoleak, 346
Type 2 endoleak, 346–347
Ultrasonography
intravscular, 353–360 neck, 246–247
Upper extremity, 23–26
Varicose vein, 113–117
Vascular disease, 297–303, 313–317
Vascular patency, 290–295
Vascular surgery, 32–37, 319–320, 338–342, 362–364
Vasoreactivity, 353–360
Vasorelaxation, 353–360
Vein
external reinforced, 113–117 saphenous, 113–117, 173–175
Vena cava. See Inferior vena cava
Venodilatation, 23–26
Venous thrombosis, 47–50
Viabahn stent graft, 297–303
Virtual reality simulation, 256–263
Volume flow, 149–153
Warfarin, 97
Wound healing
diabetic, 328–335 treprostinil sodium for, 142–148